Effect of glycerol monolaurate on bacterial growth and toxin production
Open accessThe DOI matches its Crossref record.
Abstract
Glycerol monolaurate (GML) is a naturally occurring surfactant that has potential use as an additive to tampons and wound dressings to reduce the incidence of certain bacterial toxin-mediated illnesses. In vitro studies were undertaken to evaluate the effect of GML on the growth of and toxin production by potentially pathogenic bacteria. GML inhibited the growth of clinical isolates of group A, B, F, and G streptococci at concentrations of 10 to 20 micrograms/ml. Exotoxin production, including that of pyrogenic exotoxins and hemolysins, was reduced by concentrations of GML that were below those inhibitory for growth as well as growth inhibitory. The growth of Staphylococcus aureus strains from patients with toxic shock syndrome and scalded skin syndrome was inhibited or delayed in the presence of 100 to 300 micrograms of GML per ml. Growth inhibition by GML could be overcome by the production of lipase. S. aureus elaboration of hemolysin, toxic shock syndrome toxin 1, and exfoliative toxin A was inhibited at GML concentrations below those necessary to inhibit growth. Results similar to those for S. aureus were obtained in tests of S. hominis. Escherichia coli growth and Salmonella minnesota growth were unaffected by GML, but an S. minnesota Re mutant was susceptible to growth-inhibitory activity. Endotoxin release into the medium from E. coli cells was also unaffected by GML, but the release or activity of E. coli hemolysin was increased by GML. Streptococcal pyrogenic endotoxin A production by an E. coli clone was not affectd by GML. These studies indicate that GML is effective in blocking or delaying the production of exotoxins by pathogenic gram-positive bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glycerol monolaurate prevents mucosal SIV transmission
Li, Q., Estes, J. D., Schlievert, P. M., Duan, L., Brosnahan, A. J., Southern, P. J., Reilly, C. S., Peterson, M. L., Schultz-Darken, N., Brunner, K. G., et al. (2009) · Nature · doi:10.1038/nature07831 · Cited by 638
Self-citationStaphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
Self-citationThe Properties of Lauric Acid and Their Significance in Coconut Oil
Dayrit, F. M. (2015) · Journal of the American Oil Chemists' Society · doi:10.1007/s11746-014-2562-7 · Cited by 479
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Early Events in Sexual Transmission of HIV and SIV and Opportunities for Interventions
Haase, A. T. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-080709-124959 · Cited by 321
Yarwood, J. M., McCormick, J. K., & Schlievert, P. M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.4.1113-1123.2001 · Cited by 318
Self-citationThe Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin
Clarke, S. R., Mohamed, R., Bian, L., Routh, A. F., Kokai-Kun, J. F., Mond, J. J., Tarkowski, A., & Foster, S. J. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.04.005 · Cited by 225
Glycerol monolaurate antibacterial activity in broth and biofilm cultures.
Schlievert, P. M., & Peterson, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040350 · Cited by 198
Self-citationPreuss, H. G., Echard, B., Enig, M., Brook, I., & Elliott, T. B. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-6604-1 · Cited by 180
“Monolaurin is effective in blocking or delaying production of exotoxins by pathogenic gram-positive bacteria [33] and inhibits the synthesis of most staphylococcal and other exoproteins at the level of transcription [34].”
BackgroundProjan, S. J., Brown-Skrobot, S., Schlievert, P. M., Vandenesch, F., & Novick, R. P. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.14.4204-4209.1994 · Cited by 151
“We have recently observed that the surfactant glycerol monolaurate (GML) inhibits the production of toxic shock syndrome toxin-1 (TSST-1), the toxin responsible for toxic shock syndrome (4, 5), by Staphylococcus aureus and also of the streptococcal erythrogenic toxin SpeA (3, 26).”
BackgroundSelf-citationRuzin, A., & Novick, R. P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.9.2668-2671.2000 · Cited by 105
Self-citationGlycerol Monolaurate (GML) inhibits human T cell signaling and function by disrupting lipid dynamics
Zhang, M. S., Sandouk, A., & Houtman, J. C. D. (2016) · Scientific Reports · doi:10.1038/srep30225 · Cited by 81
The clinical use of monolaurin as a dietary supplement: a review of the literature.
Barker, L. A., Bakkum, B. W., & Chapman, C. (2019) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2019.02.004 · Cited by 23
Schlievert, P. M., Kilgore, S. H., Kaus, G. M., Ho, T. D., & Ellermeier, C. D. (2018) · mSphere · doi:10.1128/mspheredirect.00597-18 · Cited by 21
“Previously, it was shown that GML prevents exotoxin production by Gram-positive bacteria at concentrations that do not kill toxin-producing bacteria (16, 19, 23).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Schlievert, P. M., Deringer, J. R., Kim, M. H., Projan, S. J., & Novick, R. P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1992-03
- Volume
- 36
- Issue
- 3
- Pages
- 626-631
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1992271384
- Cited by
- 127
- References
- 0
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.